Panel Orders UnitedHealthcare to pay $10.8M for Allegedly Underpaying Physicians
The lawsuit is one of nine cases throughout the country that TeamHealth has brought against United for alleged underpayments. The other eight cases are still ongoing.
UnitedHealthcare plans big Medicare Advantage expansion for 2021
The insurer plans to increase the footprint for its Medicare Advantage plans by adding 300 additional counties to its service area.
Justice Department approves $69 billion CVS Health-Aetna deal
Regulatory approval for the purchase is predicated on Aetna's previously announced plans to sell off its Medicare Part D business to WellCare Health.
Color secures widespread coverage for its hereditary cancer test
Is hereditary cancer screening really worth it for the general population? Increasingly, the answer is 'yes.'
Announcing 50+ Innovation Leaders: A Collaboration With AARP and MedCity News
The 50+ healthcare market is thriving, and we want to showcase those leading the charge. MedCity and AARP are issuing a call for nominations of innovators developing exciting products and services for the 50+ market. Finalists will be chosen by our readers as the 50+ Innovation Leaders.
Obamacare marketplace is unstable
Tuesday, UnitedHealthcare announced that they suffered huge financial losses and are pulling back from Affordable Care Act insurance exchanges. UHC is one of the largest players in the exchanges but will be remaining in just a handful of states next year. The losses expected, according to CEO Stephen Hemsley, are expected to exceed $1 billion […]
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Who knew? Study shows having price info helps people make better healthcare choices
With more healthcare costs being shifted onto the consumer, payers, providers and policymakers alike are particularly interested in consumer patterns, but so far little research exists beyond the notion that increased choice and price transparency are important benchmarks. UnitedHealthcare, which itself launched its myHealthcare Cost Estimator in 2012 as part of that shift, sought further […]
Draft rules would help protect seniors when Medicare Advantage plans drop doctors
Federal officials are considering new Medicare Advantage rules to help protect seniors when insurers make significant reductions to their networks of doctors and other health care providers. The proposals follow UnitedHealthcare’s decision to drop thousands of doctors from its Medicare Advantage plans in at least 10 states last fall. The government’s response is part of […]
Optum’s effectiveness mash-up: Combining United’s 40M claims + 7M hospital records to test devices
SharedClarity has created an alliance of long-time healthcare frenemies (payers and providers) to test effectiveness of heart and orthopedic medical devices with the aim of lowering costs, reducing readmissions, allowing members to negotiate device pricing and getting patients effective implantable devices. For the study, United Healthcare will join forces with Baylor Healthcare System in Dallas, Dignity Health in […]
Diabetes the focus of Comcast and United Healthcare video on demand program
Comcast (NASDAQ:CMCSA, CMCSK) and UnitedHealth Group (NYSE:UNH) are launching a video-on-demand show as part of a 12-month pilot program aimed at reducing the numbers of people at risk for developing type 2 diabetes. Viewers for the video-on-demand program “Not Me” are being recruited in Philadelphia and Knoxville, Tennessee. The pilot will evaluate the effectiveness of […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.